Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 21% ± 1% |
Insufficient scRNA-seq data for expression of TDRD5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 85% | 286.01 | 391 / 459 | 92% | 10.33 | 1027 / 1118 |
thymus | 99% | 139.13 | 644 / 653 | 33% | 1.00 | 199 / 605 |
prostate | 76% | 79.11 | 185 / 245 | 49% | 1.18 | 247 / 502 |
stomach | 57% | 27.26 | 204 / 359 | 54% | 2.06 | 155 / 286 |
bladder | 52% | 48.62 | 11 / 21 | 59% | 3.23 | 295 / 504 |
kidney | 100% | 140.21 | 89 / 89 | 9% | 0.24 | 81 / 901 |
esophagus | 34% | 23.03 | 491 / 1445 | 73% | 4.68 | 134 / 183 |
intestine | 49% | 45.74 | 471 / 966 | 58% | 1.92 | 306 / 527 |
pancreas | 41% | 15.00 | 133 / 328 | 49% | 2.01 | 88 / 178 |
ovary | 16% | 9.69 | 28 / 180 | 74% | 2.86 | 320 / 430 |
adrenal gland | 55% | 37.38 | 141 / 258 | 26% | 0.91 | 59 / 230 |
lung | 19% | 7.01 | 109 / 578 | 58% | 4.26 | 675 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 76% | 4.54 | 34 / 45 |
brain | 68% | 101.56 | 1805 / 2642 | 7% | 0.12 | 48 / 705 |
skin | 59% | 39.72 | 1067 / 1809 | 10% | 0.30 | 46 / 472 |
uterus | 5% | 2.52 | 9 / 170 | 49% | 2.89 | 223 / 459 |
adipose | 46% | 27.39 | 548 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 26% | 12.37 | 341 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.38 | 9 / 80 |
liver | 0% | 0.28 | 1 / 226 | 10% | 0.50 | 39 / 406 |
spleen | 5% | 1.33 | 11 / 241 | 0% | 0 | 0 / 0 |
heart | 2% | 0.77 | 17 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.33 | 5 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.02 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030719 | Biological process | P granule organization |
GO_0007283 | Biological process | spermatogenesis |
GO_0007286 | Biological process | spermatid development |
GO_0141007 | Biological process | siRNA-mediated retrotransposon silencing by heterochromatin formation |
GO_0034587 | Biological process | piRNA processing |
GO_0071546 | Cellular component | pi-body |
GO_0033391 | Cellular component | chromatoid body |
GO_0045202 | Cellular component | synapse |
GO_0043186 | Cellular component | P granule |
Gene name | TDRD5 |
Protein name | Tudor domain containing 5 Tudor domain-containing protein 5 |
Synonyms | hCG_2024910 TUDOR3 |
Description | FUNCTION: Required during spermiogenesis to participate in the repression transposable elements and prevent their mobilization, which is essential for the germline integrity. Probably acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for chromatoid body (CB) assembly (By similarity). . FUNCTION: Required during spermiogenesis to participate in the repression transposable elements and prevent their mobilization, which is essential for the germline integrity. Probably acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for chromatoid body (CB) assembly. . |
Accessions | ENST00000444136.6 [Q8NAT2-1] Q8NAT2 ENST00000367614.5 [Q8NAT2-3] ENST00000417329.1 A0A0C4DG74 ENST00000294848.12 [Q8NAT2-3] A0A024R910 |